Skip to Content

168 168 (Fenofibric Acid Delayed-Release 135 mg)

Pill with imprint 168 168 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Graviti Pharmaceuticals Inc..

Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 168 168

Fenofibric Acid Delayed-Release

Imprint
168 168
Strength
135 mg
Color
Blue & Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Graviti Pharmaceuticals Inc.
National Drug Code (NDC)
69844-0023

Get help with Imprint Code FAQs.

Related Images for "168 168"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.